company

TERAPIBYGG AS

5124 MORVIK

Return on Equity
11,29 %
Current Ratio
1,03
Debt-to-Equity Ratio
1,64
Key figures (NOK)2022
Revenue541 000
Net Income131 000
Total Assets3 254 000
Total Equity1 160 000
Income (NOK)2022
Revenue541 000
Expenditure249 000
Operating Profit292 000
Financial Income0
Financial Costs99 000
Financial Balance−99 000
Earnings Before Tax194 000
Tax63 000
Net Income131 000
Balance (NOK)2022
Total Fixed Assets3 055 000
Total Current Assets199 000
Total Assets3 254 000
Total Retained Equity1 060 000
Total Equity1 160 000
Total Long-Term Debt1 900 000
Total Current Debt194 000
Total Equity and Debt3 254 000
Cash flow (NOK)2022
Sales Income0
Other Income541 000
Revenue541 000
Cost of Goods Sold0
Salary Costs0
Depreciation137 000
Impairment0
Expenditure249 000
Operating Profit292 000
Financial Income0
Financial Costs99 000
Financial Balance−99 000
Dividends200 000
Net Income131 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate3 055 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets3 055 000
Total Fiancial Fixed Assets0
Total Fixed Assets3 055 000
Stock0
Total Investments0
Cash, Bank199 000
Total Current Assets199 000
Total Assets3 254 000
Total Equity1 160 000
Short-Term Group Debt0
Total Long-Term Debt1 900 000
Creditors1 000
Unpaid Taxes0
Dividends200 000
Other Current Debt130 000
Total Current Debt194 000
Total Equity and Debt3 254 000
Financial indicators2022
Return on Equity11,29 %
Debt-to-Equity Ratio1,64
Operating Profit Margin53,97 %
Current Ratio1,03
Quick Ratio1,03
Equity Ratio0,36
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English